Novo Integrated Sciences' Subsidiary, Clinical Consultants International, Signs Sales & Consulting Agreement with Smart Healthcare Solution Provider, TiaTech USA Inc.

Author's Avatar
Nov 08, 2022

Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), and Clinical Consultants International (“CCI”), a Novo wholly-owned subsidiary, today announced the signing of a Sales and Consulting Agreement (the “Agreement”), which includes revenue-sharing potential, with TiaTech USA Inc. (“TiaTech”), a leader in state-of-the-art health tech solutions.